Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 4:13 PM ET


Company Overview of Merck & Co. Inc.

Executive Profile

Thomas R. Cech Ph.D.

Independent Director, Member of Audit Committee and Member of Research Committee, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Dr. Thomas R. Cech, Tom, Ph.D., has been a Director at Merck & Co. Inc. since May 27, 2009. He serves as Trustee of Grinnell College. He serves as a Director of the Colorado Initiative in Molecular Biotechnology. He has been the Distinguished Professor of Chemistry and Biochemistry at the University of Colorado, Biofrontiers Institute-Boulder since 1990. He was a Special Advisor of Morgenthaler since 2010. Dr. Cech specializes in evaluating early-stage biotechnology ...

Corporate Headquarters

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships

Independent Director, Member of Audit Committee and Member of Research Committee


Post-Doctoral Training
Massachusetts Institute of Technology
PhD 1975
University of California Berkeley
BA 1970
Grinnell College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$266,532
Total Calculated Compensation$266,532

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
Olivier Brandicourt Chief Executive Officer, Director and Member of Strategy Committee
Severin Schwan Ph.D.Chief Executive Officer and Executive Director
Roche Holding AG
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Merck & Co. Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at